English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 9 July 2024, 23:10 HKT/SGT
Share:
    

Source: AIVF
AIVF Set to Transform the IVF Process With AI Technology in the Australian Market
AIVF, a leading innovator in fertility technology, is thrilled to announce that its cutting-edge AI-driven solutions are now available in the Australian market.

MELBOURNE, July 9, 2024 - (ACN Newswire) - AIVF, a leading innovator in fertility technology, is thrilled to announce that its cutting-edge AI-driven solutions are now available in the Australian market. This milestone brings the promise of enhanced fertility treatments and improved success rates to clinics and patients across Australia.

AIVF's groundbreaking technology is designed to accelerate the time to pregnancy and increase predicted clinical pregnancy success rates, by leveraging advanced artificial intelligence. The inclusion in the Australian market ensures that patients now have access to some of the most sophisticated and well-tested fertility technologies available.

This achievement is the result of five years of intensive research, during which tens of thousands of embryos were analyzed using state-of-the-art AI models and data from five continents. This rigorous process underscores AIVF's commitment to quality and excellence in reproductive health technologies.

"We are excited to bring our innovative solutions to Australia, marking a significant step forward in our mission to support individuals and couples on their journey to parenthood," said Daniella Gilboa, CEO and Co-founder of AIVF. "Our technology is designed to provide a higher standard of care, improving clinical outcomes and optimizing the IVF process."

AIVF's platform enhances the IVF process through predictive analytics and decision support for all Relevant Health Professionals - such as a registered medical practitioner. This technology aims to improve success rates and optimize outcomes for fertility treatment patients, from early-stage embryo evaluation to genetic testing.

Clinics in Australia can now integrate AIVF's solutions into their offerings, providing speedier, more accurate, and seamless IVF treatments. Patients will benefit from less invasive procedures, greater transparency, and higher success rates, ultimately leading to faster times to pregnancy.

This expansion marks a new era in IVF treatment, and AIVF invites clinics and patients across Australia to be part of this groundbreaking transformation.

For more information about AIVF and its innovative fertility solutions, please visit AIVF.co.

About AIVF

AIVF is at the forefront of fertility technology, dedicated to advancing reproductive health through artificial intelligence and data-driven solutions. Their mission is to support fertility clinics and their patients by providing innovative tools that enhance the IVF process and improve clinical outcomes.

Contact Information
Eyal Katz
VP Marketing
eyalk@aivf.co
+972542413730

SOURCE: AIVF



Topic: Press release summary
Source: AIVF

Sectors: Healthcare & Pharm, Artificial Intel [AI]
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
SMG SHAREHOLDER ACTION ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit against Scotts Miracle-Gro (SMG) and Lead Plaintiff Deadline on August 5, 2024  
July 23, 2024 23:30 HKT/SGT
CGFNS International Joins WHO Stakeholder Network to Advance Rehabilitation Care  
July 23, 2024 22:00 HKT/SGT
TERADATA CLASS ACTION ALERT: Kaplan Fox Encourages Investors to Contact the Firm Before Lead Plaintiff Deadline of August 13, 2024  
July 23, 2024 21:48 HKT/SGT
Eisai to Present Dual-Acting Lecanemab Three-Year Efficacy and Safety Data and Discuss Long-Term Outcomes of Continued Treatment at the Alzheimer's Association International Conference 2024  
Tuesday, July 23, 2024 7:23:00 PM
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases  
July 23, 2024 19:16 HKT/SGT
U.S. Polo Assn. Announces Continued Partnership with Polo Club du Domaine Chantilly Throughout Summer 2024  
July 23, 2024 19:00 HKT/SGT
Teradata Lead Plaintiff Deadline: Kaplan Fox Encourages Investors to Contact the Firm Before Lead Plaintiff Deadline of August 13, 2024  
July 23, 2024 17:30 HKT/SGT
FTLife Officially Renamed CTF Life with the Launch of 'CTF Life - CIRCLE'  
July 23, 2024 16:01 HKT/SGT
Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program  
July 23, 2024 16:00 HKT/SGT
Alta Partners with Australia's Ray White Capital Enhancing Access to Private Real Estate Opportunities  
July 23, 2024 15:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575